Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health, through the Pharmaceutical Division (PD), is currently crafting the new medium-term Philippine Medicines Policy (PMP) to be implemented from the years 2022 to 2030. The policy document outlines an 8-year continue reading : Public Consultation for the Philippine Medicines Policy 2022-2030